Directory
>
Beth Weinberg
Beth Weinberg
Sr Vice President Regulatory Affairs and Quality Assurance | Cara Therapeutics
Carmel, Indiana, United States
Beth Weinberg
Summary
Beth Weinberg is a seasoned regulatory affairs professional with over 28 years of experience in the pharmaceutical industry, specializing in drug development and regulatory strategies. She currently serves as the Senior Vice President of Regulatory Affairs and Quality Assurance at Cara Therapeutics. Her career has spanned various roles in both large pharmaceutical companies and innovative biotech firms, showcasing her ability to navigate complex regulatory landscapes. Beth has a proven track record in managing successful regulatory submissions and fostering strong relationships with global stakeholders. Passionate about all phases of regulatory work, she has made significant contributions to the development of therapies in diabetes and other therapeutic areas. Beth's educational background includes a B.S. in Pharmacy from Butler University and a B.A. in Liberal Arts from Bradley University. She is known for her strategic thinking and leadership in regulatory affairs, having played pivotal roles in multiple NDA submissions.
Beth Weinberg
Work Experience
Sr Vice President Regulatory Affairs and Quality Assurance at
Cara Therapeutics
February 2022 - Present
Vice President Regulatory Affairs at
Angion
January 2021 - January 2022
Vice President Regulatory Affairs at
Roivant Sciences
June 2020 - December 2020
Head Of Regulatory Affairs and Quality at
Metavant Sciences
July 2018 - May 2020
Director, US Regulatory Affairs at
Eli Lilly and Company
February 2006 - June 2018
Scientific Communications, Medical, Regulatory at
Eli Lilly and Company
May 2000 - January 2006
Clinical Research Associate/Manager at
Eli Lilly and Company
May 1995 - April 2000
Hospital Sales Representative at
Abbott Co
October 1987 - September 1991
Beth Weinberg
Education
January 1991 - January 1995
January 1983 - January 1987
Frequently Asked Questions about Beth Weinberg
What is Beth Weinberg email address?
Beth Weinberg's primary email address is *********@angion.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Beth Weinberg work for?
Beth Weinberg is a Sr Vice President Regulatory Affairs and Quality Assurance at Cara Therapeutics, a company specializing in Commercial physical research.
Where Beth Weinberg graduated from?
Beth Weinberg holds a degree in Pharmacy from Butler University.
How can I directly contact Beth Weinberg?
To contact Beth Weinberg directly, you can use the email address *********@angion.com. Complete contact information is available upon registration with Muraena.
Who is Beth Weinberg?
Beth Weinberg is a seasoned regulatory affairs professional with over 28 years of experience in the pharmaceutical industry, specializing in drug development and regulatory strategies. She currently serves as the Senior Vice President of Regulatory Affairs and Quality Assurance at Cara Therapeutics. Her career has spanned various roles in both large pharmaceutical companies and innovative biotech firms, showcasing her ability to navigate complex regulatory landscapes. Beth has a proven track record in managing successful regulatory submissions and fostering strong relationships with global stakeholders. Passionate about all phases of regulatory work, she has made significant contributions to the development of therapies in diabetes and other therapeutic areas. Beth's educational background includes a B.S. in Pharmacy from Butler University and a B.A. in Liberal Arts from Bradley University. She is known for her strategic thinking and leadership in regulatory affairs, having played pivotal roles in multiple NDA submissions.
Beth`s contact details
*********@angion.com
*********@caratherapeutics.com
Colleagues
Chief Financial Officer
Executive Director, HR
Vice President, Head of Accounting and Controller
Chief Executive Officer
General Counsel, Secretary and Chief Compliance Officer
President &CEO
Executive Director, Regulatory Affairs
Executive Director, Information Technology
President and CEO